NAD+ has no pharmaceutical marketing authorisation for any therapeutic indication. Meta-analyses of NMN (an NAD+ precursor) randomised controlled trials have found that while supplementation elevat...
View full compound profile →Vendors stocking
25
across 7 countries
Total listings
32
26 in stock
Price range
£20.99–£495.00
Median price per mg
£0.15
Most common size
500mg
11 listings
Forms available
pre-mixed pen, Vial
Stock health
81%
22 vendors · 26 listings
12 vendors · 17 listings
£20.99–£495.00
Avg £0.22/mg
4 vendors · 4 listings
CA$34.99–CA$94.99
Avg CA$0.16/mg
3 vendors · 3 listings
€99.95–€139.00
Avg €0.12/mg
3 vendors · 5 listings
$51.00–$130.00
Avg $0.27/mg
1 vendor · 1 listing
€154.00
1 vendor · 1 listing
zł100.41
Avg zł10.04/mg
1 vendor · 1 listing
kr899.00
Avg kr0.90/mg
10ml
1 listing
Avg price: £100.41
Avg per mg: £10.04
100mg
1 listing
Avg price: £51.00
Avg per mg: £0.51
250mg
1 listing
Avg price: £55.00
Avg per mg: £0.22
500mg
11 listings
Avg price: £113.72
Avg per mg: £0.23
550mg
1 listing
Avg price: £94.99
Avg per mg: £0.17
600mg
1 listing
Avg price: £130.00
Avg per mg: £0.22
1000mg
6 listings
Avg price: £260.49
Avg per mg: £0.26
This compound is sold as a research chemical and is not approved for human use. Information on this page is compiled from publicly available vendor listings and is provided for informational purposes only. PeptideTrace does not sell peptides, does not facilitate transactions, and does not recommend any vendor. Always verify product quality independently.
Prices last updated: 15 May 2026
Data sourced from 25 vendor websites across 7 countries
